SK
Sebastian Kreuz
Investment Manager at Boehringer Ingelheim
Ingelheim am Rhein, Rhineland-Palatinate
Overview
Sebastian Kreuz is currently serving as the Executive Director and Investment Manager at Boehringer Ingelheim Venture Fund, focusing on investments in pharmaceuticals at stages like Seed and Series A. With a background in drug discovery, he has led investments in companies like smartbax and Centauri Therapeutics, showcasing his expertise in novel therapeutic modalities and the pharmaceutical industry.
Work Experience
Executive Director / Investment Manager (BI Venture Fund)
2019 - Current
Boehringer Ingelheim Venture Fund (BIVF) at Boehringer Ingelheim
Associate Director (Research Beyond Borders)
2015 - 2019
Gene Therapy Group (Research Beyond Borders) at Boehringer Ingelheim
Project Leader (Immunology & Respiratory Diseases Research)
2013 - 2015
Immunology & Respiratory Diseases Research (I&R) at Boehringer Ingelheim
Laboratory Head (Target Discovery Research)
2006 - 2012
Target Discovery Research (TDR) at Boehringer Ingelheim
Postdoctoral Researcher (Functional Genomics)
2004 - 2005
Global Skill Center Functional Genomics at Boehringer Ingelheim